Cargando…
Reliability and Validity of the Chinese Version of FACIT-AI, a New Tool for Assessing Quality of Life in Patients with Malignant Ascites
Objective: The study objective was to determine the reliability and validity of the Chinese version of the Functional Assessment of Chronic Illness Therapy – Ascites Index (FACIT-AI). Methods: A forward-backward translation procedure was adopted to develop the Chinese version of the FACIT-AI, which...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598917/ https://www.ncbi.nlm.nih.gov/pubmed/26177329 http://dx.doi.org/10.1089/jpm.2015.0061 |
_version_ | 1782394156414402560 |
---|---|
author | Lou, Yanni Lu, Linghui Li, Yuan Liu, Meng Bredle, Jason M. Jia, Liqun |
author_facet | Lou, Yanni Lu, Linghui Li, Yuan Liu, Meng Bredle, Jason M. Jia, Liqun |
author_sort | Lou, Yanni |
collection | PubMed |
description | Objective: The study objective was to determine the reliability and validity of the Chinese version of the Functional Assessment of Chronic Illness Therapy – Ascites Index (FACIT-AI). Methods: A forward-backward translation procedure was adopted to develop the Chinese version of the FACIT-AI, which was tested in 69 patients with malignant ascites. Cronbach's α, split-half reliability, and test-retest reliability were used to assess the reliability of the scale. The content validity index was used to assess the content validity, while factor analysis was used for construct validity and correlation analysis was used for criterion validity. Results: The Cronbach's α was 0.772 for the total scale, and the split-half reliability was 0.693. The test-retest correlation was 0.972. The content validity index for the scale was 0.8–1.0. Four factors were extracted by factor analysis, and these contributed 63.51% of the total variance. Item-total correlations ranged from 0.591 to 0.897, and these were correlated with visual analog scale scores (correlation coefficient, 0.889; P<0.01). Conclusions: The Chinese version of the FACIT-AI has good reliability and validity and can be used as a tool to measure quality of life in Chinese patients with malignant ascites. |
format | Online Article Text |
id | pubmed-4598917 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Mary Ann Liebert, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-45989172015-10-20 Reliability and Validity of the Chinese Version of FACIT-AI, a New Tool for Assessing Quality of Life in Patients with Malignant Ascites Lou, Yanni Lu, Linghui Li, Yuan Liu, Meng Bredle, Jason M. Jia, Liqun J Palliat Med Original Articles Objective: The study objective was to determine the reliability and validity of the Chinese version of the Functional Assessment of Chronic Illness Therapy – Ascites Index (FACIT-AI). Methods: A forward-backward translation procedure was adopted to develop the Chinese version of the FACIT-AI, which was tested in 69 patients with malignant ascites. Cronbach's α, split-half reliability, and test-retest reliability were used to assess the reliability of the scale. The content validity index was used to assess the content validity, while factor analysis was used for construct validity and correlation analysis was used for criterion validity. Results: The Cronbach's α was 0.772 for the total scale, and the split-half reliability was 0.693. The test-retest correlation was 0.972. The content validity index for the scale was 0.8–1.0. Four factors were extracted by factor analysis, and these contributed 63.51% of the total variance. Item-total correlations ranged from 0.591 to 0.897, and these were correlated with visual analog scale scores (correlation coefficient, 0.889; P<0.01). Conclusions: The Chinese version of the FACIT-AI has good reliability and validity and can be used as a tool to measure quality of life in Chinese patients with malignant ascites. Mary Ann Liebert, Inc. 2015-10-01 /pmc/articles/PMC4598917/ /pubmed/26177329 http://dx.doi.org/10.1089/jpm.2015.0061 Text en © Yanni Lou, Linghui Lu, Yuan Li, Meng Liu, Jason M. Bredle, Liqun Jia 2015; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Original Articles Lou, Yanni Lu, Linghui Li, Yuan Liu, Meng Bredle, Jason M. Jia, Liqun Reliability and Validity of the Chinese Version of FACIT-AI, a New Tool for Assessing Quality of Life in Patients with Malignant Ascites |
title | Reliability and Validity of the Chinese Version of FACIT-AI, a New Tool for Assessing Quality of Life in Patients with Malignant Ascites |
title_full | Reliability and Validity of the Chinese Version of FACIT-AI, a New Tool for Assessing Quality of Life in Patients with Malignant Ascites |
title_fullStr | Reliability and Validity of the Chinese Version of FACIT-AI, a New Tool for Assessing Quality of Life in Patients with Malignant Ascites |
title_full_unstemmed | Reliability and Validity of the Chinese Version of FACIT-AI, a New Tool for Assessing Quality of Life in Patients with Malignant Ascites |
title_short | Reliability and Validity of the Chinese Version of FACIT-AI, a New Tool for Assessing Quality of Life in Patients with Malignant Ascites |
title_sort | reliability and validity of the chinese version of facit-ai, a new tool for assessing quality of life in patients with malignant ascites |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598917/ https://www.ncbi.nlm.nih.gov/pubmed/26177329 http://dx.doi.org/10.1089/jpm.2015.0061 |
work_keys_str_mv | AT louyanni reliabilityandvalidityofthechineseversionoffacitaianewtoolforassessingqualityoflifeinpatientswithmalignantascites AT lulinghui reliabilityandvalidityofthechineseversionoffacitaianewtoolforassessingqualityoflifeinpatientswithmalignantascites AT liyuan reliabilityandvalidityofthechineseversionoffacitaianewtoolforassessingqualityoflifeinpatientswithmalignantascites AT liumeng reliabilityandvalidityofthechineseversionoffacitaianewtoolforassessingqualityoflifeinpatientswithmalignantascites AT bredlejasonm reliabilityandvalidityofthechineseversionoffacitaianewtoolforassessingqualityoflifeinpatientswithmalignantascites AT jialiqun reliabilityandvalidityofthechineseversionoffacitaianewtoolforassessingqualityoflifeinpatientswithmalignantascites |